Dr Sunwoo Lee (Liv) is a Lecturer (Assistant Prof. Equivalent) in Genomics and Bioinformatics at Aston Medical School, where she actively contributes to both teaching and research.

Dr Lee is also the Programme Co-Director for the MSc and MRes in Bioinformatics and Genomic Medicine at Aston University.

Dr Lee completed her undergraduate degree in South Korea and obtained both her MPhil and PhD at the University of Cambridge in the field of Genomic Medicine (awarded in 2024). Her doctoral research focused on investigating the causes of rare genetic disorders (imprinting and neurodevelopmental disorders), and on establishing robust diagnostic criteria for these conditions using epigenomic approaches.

Her postgraduate training was supported by a four-year Studentship Award from the Rosetrees Trust, and research funding from the NIHR Cambridge Biomedical Research Centre (BRC). During her PhD, Dr Lee conducted research on improving diagnostic strategies for rare diseases, particularly epigenetic and paediatric disorders, through DNA methylation profiling and genome-wide epigenomic analysis.

From 2024, Dr Lee continued her academic career as a Postdoctoral Research Fellow at the Academic Laboratory of Medical Genetics, University of Cambridge, where she worked for a further two years. Her postdoctoral research involved the development of targeted next-generation sequencing (NGS) pipelines based on methylation episignatures and the analysis of clinical cases to establish novel diagnostic workflows. This work has led to extensive national and international collaborations across the UK, Europe, and South Korea, involving close interaction with medical and clinical teams.

Dr Lee has published extensively in the field of methylation episignature analysis and epigenetic diagnostics, with peer-reviewed publications. Her research aims to translate epigenomic signatures into clinically actionable diagnostic tools and to integrate methylation data with computational and machine-learning approaches to support variant interpretation in rare genetic disorders.

2023-2025 Research Associate/Bioinformatician (University of Cambridge)
2024-2025 Researcher (AmtixBio, Pharmaceutical Company, South Korea)
2018-2019 Research Assistant (Cancer Molecular Diagnostic Laboratory, Cambridge University Hospitals)

• Epigenetic analysis and diagnostics of rare epigenetic disorders (imprinting, chromatin, neurodevelopmental disorders)
• Epigenetic drug discovery, development and therapeutics
• Cancer epigenetics